Author(s): Clayton K.; Mciver A.; Bougler A.; Buckle C.; Butler C.; Draffen J.; Earl S.; Jeffs Y.; Jones S.; Jordan C.; Morley J.; Neal H.; Newbold S.; Roberts J.; Rose P.; Shepherd P.; Smith B.
Source: Journal of Thoracic Oncology; Oct 2019; vol. 14 (no. 10)
Publication Date: Oct 2019
Publication Type(s): Conference Abstract
Abstract:Background: The NLCFN workshop group were keen to explore the impact on patient experience of the National Optimal Lung Cancer Pathway (NOLCP). Evaluation of patient experience to collect data on their corresponding pathways. Hospital based lung cancer diagnostic services across the UK at 18 Trusts. Method(s): Newly diagnosed lung cancer patients referred on the 62 day pathway during October 2017 to July 2018 were eligible. 135 patient pathway and questionnaire data were analysed from 15 Trusts. Data Collection Data collection was in two parts: A patient survey and a data collection tool to reflect key points along the patient pathway. All data was anonymised. Data Analysis Data was submitted by 15 Trusts and analysed by the workshop participants Result: Overall, patients were satisfied with their experience of the pathway. Data collection demonstrated significant variation across pathways. Service evaluation and development is a key part of the LCNS role, however there were variations in Trust governance processes which caused delays and non submissions. Conclusion(s): Overall, patients were satisfied with their experience of the pathway. Data collection demonstrated significant variation across pathways. Service evaluation and development is a key part of the LCNS role, however there were variations in Trust governance processes which caused delays and non submissions. Keywords: Patient, experience, lung cancer
Copyright © 2019
Database: EMBASE